– New preclinical data presented at AACR Annual Meeting 2022 –
– Intravenous exosome candidate engineered for tropism precisely targets transcription factors in myeloid cell subpopulations –
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
– New preclinical data presented at AACR Annual Meeting 2022 –
– Intravenous exosome candidate engineered for tropism precisely targets transcription factors in myeloid cell subpopulations –
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| CDAK | 0.0570 | -0.0725 | -55.98% |
| Codiak Biosciences Inc | |||